HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[Co-tetroxazin (Tibirox) and doxycycline (Vibramycin) in treatment of upper respiratory tract infections: a double-blind study]

AuthorsM Podvinec
JournalTherapeutische Umschau. Revue thérapeutique (Ther Umsch) Vol. 39 Issue 10 Pg. 815-20 (Oct 1982) ISSN: 0040-5930 [Print] SWITZERLAND
Vernacular TitleCo-tetroxazin (Tibirox) und Doxycyclin (Vibramycin) in der Behandlung von Infekten der Oberen Luftwege: eine Doppelblindstudie.
PMID6760445 (Publication Type: Clinical Trial, Comparative Study, English Abstract, Journal Article, Randomized Controlled Trial)
Chemical References
  • Anti-Infective Agents
  • Drug Combinations
  • Pyrimidines
  • Doxycycline
  • Sulfadiazine
  • co-tetroxazin
Topics
  • Adolescent
  • Adult
  • Anti-Infective Agents (therapeutic use)
  • Clinical Trials as Topic
  • Double-Blind Method
  • Doxycycline (therapeutic use)
  • Drug Combinations (therapeutic use)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Otitis Media (drug therapy)
  • Pyrimidines (therapeutic use)
  • Respiratory Tract Infections (drug therapy)
  • Sinusitis (drug therapy)
  • Sulfadiazine (therapeutic use)
  • Tonsillitis (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD